文献速递心外重症与机械循环支持

心脏移植后严重早期移植物功能障碍:两种临床轨迹及舒张期灌注压对机械循环支持的预测作用

Severe early graft dysfunction post-heart transplantation: Two clinical trajectories and diastolic perfusion pressure as a predictor of mechanical circulatory support.
PubMed 文献 · J Heart Lung Transplant · 2024-09-12

本研究为两中心216例连续心脏移植患者的回顾性分析,将严重早期移植物功能障碍按移植后机械循环支持时机分为「立即」术中支持与「延迟」术后支持,发现两组危险因素和1年生存率显著不同,延迟支持与较低舒张期灌注压和较高去甲肾上腺素等效剂量相关,提示血管麻痹是主要病理生理机制。

要点

  • 严重早期移植物功能障碍按机械循环支持时机可分为「立即」术中支持与「延迟」术后支持两种轨迹。
  • 「立即」支持组1年死亡率最高,为34.9%,显著高于无支持和「延迟」支持组。
  • 延迟支持与较低舒张期灌注压和较高去甲肾上腺素等效剂量独立相关,提示血管麻痹主导。

核心结论

  • 「立即」与「延迟」移植后机械循环支持的严重早期移植物功能障碍患者,其危险因素和1年生存率显著不同。
  • 「延迟」机械循环支持与较低舒张期灌注压和较高去甲肾上腺素等效剂量相关,符合血管麻痹为主要病理生理机制。

研究设计与样本

  • 两中心连续216例心脏移植患者的回顾性研究。
  • 收集受者、供者、血管升压药剂量及入ICU时(T0)和入ICU后6小时(T6)的血流动力学数据。

主要发现

  • 216例中67例发生严重早期移植物功能障碍,其中「立即」机械循环支持43例,「延迟」机械循环支持24例。
  • 以「无机械循环支持」为参照的多项回归分析显示,「立即」机械循环支持的可能性随热缺血时间和体外循环时间增加而增加,但「延迟」机械循环支持无此关联。
  • 1年死亡率在「立即」机械循环支持组最高,为34.9%,「无机械循环支持」组为3.4%,「延迟」机械循环支持组为8%(p < 0.001)。
  • 在移植后未立即接受机械循环支持的患者中,T6时舒张期灌注压和去甲肾上腺素等效剂量与后续「延迟」机械循环支持独立相关。
  • 去甲肾上腺素等效剂量≥0.2 mcg/kg/min预测「延迟」机械循环支持的敏感性和特异性分别为71%和81%;舒张期灌注压≥40 mmHg预测「无机械循环支持」的敏感性和特异性分别为83%和74%;系统血管阻力对「延迟」机械循环支持的区分价值较差。

关键数值与推荐

  • 严重早期移植物功能障碍定义为心脏移植后24小时内需要机械循环支持。
  • 舒张期灌注压=舒张压-中心静脉压。
  • 去甲肾上腺素等效剂量为血管升压药剂量之和。
  • 去甲肾上腺素等效剂量≥0.2 mcg/kg/min预测「延迟」机械循环支持的敏感性71%、特异性81%。
  • 舒张期灌注压≥40 mmHg预测「无机械循环支持」的敏感性83%、特异性74%。

临床怎么用

  • 心脏移植术后可依据机械循环支持时机将严重早期移植物功能障碍分为「立即」与「延迟」两种轨迹,两者预后不同。
  • 对于移植后未立即需要机械循环支持的患者,入ICU后6小时监测舒张期灌注压和去甲肾上腺素等效剂量有助于识别后续可能发生「延迟」机械循环支持的高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe early graft dysfunction (EGD) is defined by mechanical circulatory support (MCS) <24 hours of heart transplantation (HT). We classified severe EGD based on timing of post-HT MCS: ''Immediate'' intra-operative vs ''Delayed'' post-operative MCS (after admission into intensive care unit (ICU) from operating theater). We hypothesized that (1) risk factors and clinical course differ between ''Immediate'' and ''Delayed'' MCS; and (2) diastolic perfusion pressure (DPP=diastolic blood pressure-central venous pressure) and Norepinephrine equivalents (NE=sum of vasopressor doses), as measures of vasoplegia are related to ''Delayed'' MCS. METHODS: Two-center study of 216 consecutive patients who underwent HT. Recipient, donor, vasopressor doses and hemodynamic data at T0 and T6 (on admission and 6 hours after admission into ICU) were collected. RESULTS: Of the 216 patients, 67 patients had severe EGD (''Immediate'' MCS: n = 43, ''Delayed'' MCS: n = 24). The likelihood of ''immediate'' MCS but not ''delayed'' MCS increased with increasing warm ischemic and cardiopulmonary bypass times on multinomial regression analysis with ''no MCS'' as the referent group. One-year mortality was highest in ''Immediate'' MCS vs ''no MCS'' and ''delayed'' MCS (34.9% vs 3.4% and 8% respectively, p < 0.001). Of the patients who had no immediate post-transplant MCS, DPP and NE at T6 were independently associated with subsequent ''delayed'' MCS. Sensitivity and specificity of NE≥ 0.2 mcg/kg/min for ''Delayed'' MCS were 71% and 81%. Sensitivity and specificity of DPP of ≥40 mmHg for No MCS were 83% and 74%. The discriminatory value of systemic vascular resistance for ''Delayed'' MCS was poor. CONCLUSION: Risk factors and 1-year survival differed significantly between ''Immediate'' and ''Delayed'' post-HT MCS. The latter is related to lower DPP and higher NE, which is consistent with vasoplegia as the dominant pathophysiology.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Lim HS, Bhagra S, Berman M, et al. Severe early graft dysfunction post-heart transplantation: Two clinical trajectories and diastolic perfusion pressure as a predictor of mechanical circulatory support. J Heart Lung Transplant. 2024. PMID: 39260754. doi:10.1016/j.healun.2024.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。